Results for
"[search-keyword]"
Sponsor content
252 result(s) found, displaying 41 to 50
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INVEGA HAFYERA paliperidone (as palmitate) 1000 mg in 5 mL modified release suspension for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INVEGA HAFYERA paliperidone (as palmitate) 700 mg in 3.5 mL modified release suspension for injection pre-filled syringe.
-
Prescription medicine decision summaryTGA decision: Rybrevant (amivantamab) is approved to treat lung cancer
-
Designation or determinationProvisional determination
-
Prescription medicine registrationActive ingredients: amivantamab.
-
Australian Public Assessment Report (AusPAR)For the treatment of adult patients with relapsing forms of multiple sclerosis
-
Australian Public Assessment Report (AusPAR)AusPAR for DARZALEX SC (daratumumab) for the treatment of light chain AL amyloidosis
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for SPRAVATO esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution.
-
Prescription medicine decision summaryTGA decision: Ponvory (ponesimod) is approved to treat relapsing forms of multiple sclerosis.
-
Designation or determinationProvisional determination